Please login to the form below
New accounts: January - PR & Med Ed
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period October to December 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period October to December 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
|
|
|
|
|
|
Baxter |
Pharmacy services |
Oncology |
Succinct Communications |
|
Cephalon |
Targretin |
Oncology |
LeapFrog Medical |
|
Gr˙nenthal |
Analgesic product portfolio |
Pain |
Munro & Forster |
|
Gr˙nenthal |
Belara Publication Plan |
Gynaecology |
Zaicomm MMC |
|
Healthspan |
Various |
Vitamins and supplements |
Spink Consumer Relations |
|
MSD |
Univadis website |
N/A |
LeapFrog Medical |
|
Novo Nordisk |
Vagifem |
Local oestrogen therapy |
Spink Consumer Relations |
|
Oraldent |
Gengigel |
Oral treatment |
Ware Anthony Rust |
|
Oxfordshire Bioscience Network |
Public-private partnership promotion |
Corporate |
De Facto Communications |
|
Pfizer UK |
Macugen |
Ophthalmology |
Zaicom MMC |
|
Pfizer |
New product |
Oncology |
Succinct Communications |
|
Pfizer UK |
Vfend |
Anti-infectives |
Zaicom MMC |
|
Quintiles (International) |
Phase I trials |
Corporate communications |
Huntsworth Health |
|
Reckitt Benckiser (Global) |
Nurofen |
Pain |
Virgo Health PR |
|
Roche Products UK |
Bondronat |
Oncology |
Just:: |
|
Solvay |
Creon |
Cystic fibrosis |
LeapFrog Medical |
|
Takeda Europe |
Actos |
Type II diabetes |
The Remedy, Fleishman-Hillard |
|
Takeda Europe |
Blopress |
Hypertension |
The Remedy, Fleishman-Hillard |
|
Takeda Europe |
Prostap SR |
Prostate cancer |
The Remedy, Fleishman-Hillard |
|
Takeda Europe |
Rozerem |
Insomnia |
The Remedy, Fleishman-Hillard |
|
Takeda Europe |
International medical meetings |
N/A |
The Remedy, Fleishman-Hillard |
|
TCN |
Corporate PR |
Independent healthcare |
Zaicom MMC |
Share
Related Hub content
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
Lucid Group Communications Limited
WE’RE ON A MISSION
To transform lives through communication that changes behaviour and improves health outcomes....
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
